Is there a “mucosa-sparing” benefit of IMRT for head-and-neck cancer?

This publication has 28 references indexed in Scilit:

• Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database
  International Journal of Cancer, 2005
• Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
  The Lancet, 2003
• Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
  Radiotherapy and Oncology, 2003
• Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials
  International Journal of Radiation Oncology*Biology*Physics, 2001
• A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
  Published by Elsevier ,2000
• Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States
  Cancer, 2000
• META-ANALYSES IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
  Hematology/Oncology Clinics of North America, 1999
• Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis
  Radiotherapy and Oncology, 1998
• Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration
  Radiotherapy and Oncology, 1994
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
  Radiotherapy and Oncology, 1992